 European-listed shares of drugmakers Haleon HLN, -11.81 , GSK GSK, -8.48 and Sanofi SAN, -8.81 plunged on Thursday on worries over the Zantac heartburn medication litigation. The first trial is set to begin on Aug. 22. 